Melanocortin-4 Receptor–Deficient Mice Are Not Hypertensive or Salt-Sensitive Despite Obesity, Hyperinsulinemia, and Hyperleptinemia

No abstract is available for this paper.

• Publication year

  2005

• Venue

  HYPERTENSION

• Publication date

  2005-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.HYP.0000174327.53863.86PMID 16027245
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Hypothalamic Melanocortin 3/4-Receptors in Mediating Chronic Cardiovascular, Renal, and Metabolic Actions of Leptin

  2004cited by this paper
• Aldosterone Potentiates Angiotensin II–Induced Signaling in Vascular Smooth Muscle Cells

  2004cited by this paper
• Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes.

  2004cited by this paper
• Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats.

  2004cited by this paper
• Role of Adrenergic Activity in Pressor Responses to Chronic Melanocortin Receptor Activation

  2004cited by this paper
• The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic.

  2003cited by this paper
• Melanocortin-4 receptor messenger ribonucleic acid expression in rat cardiorespiratory, musculoskeletal, and integumentary systems.

  2003cited by this paper
• Diet‐induced obesity and cardiovascular regulation in C57BL/6J mice

  2003cited by this paper
• Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity.

  2003cited by this paper
• Genetic disruption of gamma-melanocyte-stimulating hormone signaling leads to salt-sensitive hypertension in the mouse.

  2003cited by this paper
• EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION

  2003cited by this paper
• Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction

  2003cited by this paper
• Aldosterone and Not Plasminogen Activator Inhibitor-1 Is a Critical Mediator of Early Angiotensin II/ NG-Nitro-l-Arginine Methyl Ester-Induced Myocardial Injury

  2003cited by this paper
• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

  2003cited by this paper
• Differential role of melanocortin receptor subtypes in cachexia.

  2003cited by this paper
• Role of Melanocortin-4 Receptors in Mediating Renal Sympathoactivation to Leptin and Insulin

  2003cited by this paper
• Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function

  2003cited by this paper
• Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity

  2002cited by this paper
• Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension.

  2002cited by this paper
• Cardiac Damage Prevention by Eplerenone: Comparison With Low Sodium Diet or Potassium Loading

  2002cited by this paper
• ACE Inhibition Versus Angiotensin Type 1 Receptor Antagonism: Differential Effects on PAI-1 Over Time

  2002cited by this paper
• Increasing plasma potassium with amiloride shortens the QT interval and reduces ventricular extrasystoles but does not change endothelial function or heart rate variability in chronic heart failure

  2002cited by this paper
• Sympathetic Neural Activation in Visceral Obesity

  2002cited by this paper
• Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans.

  2002cited by this paper
• Effect of Spironolactone on Impaired Fibrinolysis of Hypertensive Patients

  2002cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• Obesity--a neglected culprit in renal disease.

  2002cited by this paper
• Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why)

  2001cited by this paper
• Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats.

  2001cited by this paper
• Leptin Acts in the Central Nervous System to Produce Dose-Dependent Changes in Arterial Pressure

  2001cited by this paper
• Central melanocortin receptors regulate insulin action.

  2001cited by this paper
• Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats.

  2000cited by this paper
• A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors.

  2000cited by this paper
• Development of hypertension in a rat model of diet-induced obesity.

  2000cited by this paper
• Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure: Insights From the Randomized Aldactone Evaluation Study (RALES)

  2000cited by this paper
• A metabolic syndrome of hypertension, hyperinsulinaemia and hypercholesterolaemia in the New Zealand obese mouse

  2000cited by this paper
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• Pathophysiological role of leptin in obesity-related hypertension.

  2000cited by this paper
• Fibrinolytic function in diuretic-induced volume depletion.

  2000cited by this paper
• Obesity hypertension, salt sensitivity and insulin resistance.

  2000cited by this paper
• Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass

  2000cited by this paper
• Association between the alpha-adducin gene and hypertension in the HyperGEN Study.

  2000cited by this paper
• Association between the α-adducin gene and hypertension in the HyperGEN Study

  2000cited by this paper
• Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.

  2000cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Synergistic Effect of Adrenal Steroids and Angiotensin II on Plasminogen Activator Inhibitor-1 Production*

  1999cited by this paper
• Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defe

  1999cited by this paper
• Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products.

  1999cited by this paper
• Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis.

  1999cited by this paper
• Cardiovascular abnormalities in transgenic mice with reduced brown fat: an animal model of human obesity.

  1999cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• , Brigitte Angiotensin II Receptor Blockade and Role in Cardiac Fibrosis Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction : Effect of

  1999cited by this paper
• Response of melanocortin–4 receptor–deficient mice to anorectic and orexigenic peptides

  1999cited by this paper
• Chronic leptin infusion increases arterial pressure.

  1998cited by this paper
• Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1.

  1998cited by this paper
• High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

  1998cited by this paper
• PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events

  1997cited by this paper
• Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus.

  1997cited by this paper
• Mechanisms of abnormal renal sodium handling in obesity hypertension.

  1997cited by this paper
• Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

  1997cited by this paper
• Role of melanocortinergic neurons in feeding and the agouti obesity syndrome

  1997cited by this paper
• The effects of the angiotensin-converting enzyme inhibitor imidapril on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction.

  1997cited by this paper
• Central role of the kidney and abnormal fluid volume control in hypertension.

  1996cited by this paper
• Potentiation of angiotensin II action by corticosteroids in vascular tissue.

  1996cited by this paper
• Central role of the kidney and abnormal fluid volume control in hypertension.

  1996cited by this paper
• Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV.

  1995cited by this paper
• Renal denervation attenuates the sodium retention and hypertension associated with obesity.

  1995cited by this paper
• Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease.

  1995cited by this paper
• Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden MONICA Study.

  1994cited by this paper
• Diuretic therapy for hypertension and the risk of primary cardiac arrest.

  1994cited by this paper
• Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey

  1994cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Obesity, the sympathetic nervous system, and essential hypertension.

  1992cited by this paper
• Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.

  1992cited by this paper
• Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.

  1992cited by this paper
• The hemodynamic response to chronic hyperinsulinemia in conscious dogs.

  1991cited by this paper
• Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.

  1991cited by this paper
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

  1991cited by this paper
• The analysis of data from 2 x 2 cross-over trials with baseline measurements.

  1987cited by this paper
• High plasma concentrations of human atrial natriuretic polypeptide in aged men.

  1987cited by this paper
• On the Mechanism of Action of Triamterene: Effects on Transport of Na+, K+, and HVHCO‐3 ‐ions.

  1976cited by this paper

• Targeting gut S. aureofaciens Tü117 serves as a new potential therapeutic intervention for the prevention and treatment of hypertension.

  2025cites this paper
• The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction

  2025cites this paper
• Loss of melanocortin receptor accessory protein 2 in melanocortin-4 receptor neurons protect from obesity-associated autonomic and cardiovascular dysfunctions

  2025cites this paper
• Sarco/Endoplasmic Reticulum Ca2+ ATPase Activation Shifts Cardiac Fuel Preference Without Impairing Cardiac Function in Obese Mice

  2025cites this paper
• Genetic predisposition to obesity among adolescents: The moderator role of agility and speed

  2024cites this paper
• Salt-Sensitive Hypertension and the Kidney.

  2024cites this paper
• Leptin and Associated Neural Pathways Underlying Obesity‐Induced Hypertension

  2024cites this paper
• Low resting metabolic rate and increased hunger due to β-MSH and β-endorphin deletion in a canine model

  2024cites this paper
• Sex differences in weight gain, blood pressure control, and responses to melanocortin-4 receptor antagonism in offspring from lean and obese parents.

  2023cites this paper
• Use trends of chlorthalidone and hydrochlorothiazide among United States adults with hypertension: National Health and Nutrition Examination Survey 2009–2018

  2023cites this paper
• Melanocortin-4 receptors activate sympathetic preganglionic neurons and elevate blood pressure via TRPV1.

  2022cites this paper
• Cardiovascular Risk and Diseases in Patients With and Without Leptin-Melanocortin Pathway Variants.

  2022cites this paper
• Regulation of feeding and therapeutic application of bioactive peptides.

  2022cites this paper
• Familial early-onset obesity in Turkish children: variants and polymorphisms in the melanocortin-4 receptor (MC4R) gene

  2022cites this paper
• Signaling pathways in obesity: mechanisms and therapeutic interventions

  2022cites this paper
• The effect of gender and obesity in modulating cross-bridge function in cardiac muscle fibers

  2022cites this paper
• TRPV1-Mediated Sensing of Sodium and Osmotic Pressure in POMC Neurons in the Arcuate Nucleus of the Hypothalamus

  2022cites this paper
• Monogenic human obesity syndromes.

  2021cites this paper
• Role of the Melanocortin System in the Central Regulation of Cardiovascular Functions

  2021cites this paper
• Hypothalamic GPCR Signaling Pathways in Cardiometabolic Control

  2021cites this paper
• Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation

  2021cites this paper
• Neuroanatomical organization and functional roles of PVN MC4R pathways in physiological and behavioral regulations

  2021cites this paper
• The Centrality of Obesity in the Course of Severe COVID-19

  2021cites this paper
• Peripheral actions and direct central–local communications of melanocortin 4 receptor signaling

  2021cites this paper
• Excessive dietary salt promotes aortic stiffness in murine renovascular hypertension

  2020cites this paper
• Hypothalamic MC4R regulates glucose homeostasis through adrenaline-mediated control of glucose reabsorption via renal GLUT2 in mice

  2020cites this paper
• Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.

  2020cites this paper
• CNS Regulation of Glucose Homeostasis: Role of the Leptin-Melanocortin System

  2020cites this paper
• Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment.

  2019cites this paper
• Oxytocin Neurons Enable Melanocortin Regulation of Male Sexual Function in Mice

  2019cites this paper
• Sympathetic activity in obesity: a brief review of methods and supportive data

  2019cites this paper
• Licorice: From Pseudohyperaldosteronism to Therapeutic Uses

  2019cites this paper
• Central Glucagon-like Peptide-1 Receptor Signaling via Brainstem Catecholamine Neurons Counteracts Hypertension in Spontaneously Hypertensive Rats

  2019cites this paper
• Melanocortin-4 Receptors and Sympathetic Nervous System Activation in Hypertension

  2019cites this paper
• Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity

  2019cites this paper
• The melanocortin pathway and control of appetite-progress and therapeutic implications.

  2019cites this paper
• The Aldosterone/Renin Ratio Predicts Cardiometabolic Disorders in Subjects Without Classic Primary Aldosteronism

  2019cites this paper
• Vascular Mineralocorticoid Receptor: Evolutionary Mediator of Wound Healing Turned Harmful by Our Modern Lifestyle

  2018cites this paper
• Understanding melanocortin-4 receptor control of neuronal circuits: Toward novel therapeutics for obesity syndrome.

  2018cites this paper
• Obesity and Metabolic Syndrome Hypertension

  2018cites this paper
• Hypothalamic mechanisms underlying the cardiovascular and metabolic actions of leptin

  2018cites this paper
• Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension

  2018cites this paper
• Hypothalamic POMC or MC4R deficiency impairs counterregulatory responses to hypoglycemia in mice

  2018cites this paper
• Molecular Therapy of Melanocortin-4-Receptor Obesity by an Autoregulatory BDNF Vector

  2017cites this paper
• The role of leptin in health and disease

  2017cites this paper
• Animal Models of Metabolic Syndrome

  2017cites this paper
• Molecular Mechanisms of Sodium-Sensitive Hypertension in the Metabolic Syndrome

  2017cites this paper
• Feeling the pressure: (patho) physiological mechanisms of weight gain and weight loss in humans

  2017cites this paper
• Reduced renal sympathetic nerve activity contributes to elevated glycosuria and improved glucose tolerance in hypothalamus-specific Pomc knockout mice

  2017cites this paper
• Role of leptin in energy expenditure: the hypothalamic perspective.

  2017cites this paper
• Multi‐generational genome wide association studies identify chromosomal regions associated with ascites phenotype

  2017cites this paper
• Prevalence and phenotypic characterization of MC4R variants in a large pediatric cohort

  2017cites this paper
• Chapter 3 – Adrenocorticotrophin

  2017cites this paper
• The Role of the Autonomic Nervous System in the Pathophysiology of Obesity

  2017cites this paper
• Identification and Characterization of a Cardiomyopathy Syndrome Resulting from Loss of the Melanocortin 4 Receptor

  2017cites this paper
• Differential body weight, blood pressure and placental inflammatory responses to normal versus high-fat diet in melanocortin-4 receptor-deficient pregnant rats

  2016cites this paper
• Immunohistochemical Expression of Leptin ( Ob-protein ) in Experimentally Hypertensive Rat Kidney Tissues

  2016cites this paper
• Essential Hypertension in Children: New Mechanistic Insights

  2016cites this paper
• Neuroendocrinological and Epigenetic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic Syndrome

  2016cites this paper
• Melanocortin-4 receptor–regulated energy homeostasis

  2016cites this paper
• Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor

  2016cites this paper
• Bombesin-like receptor 3 regulates blood pressure and heart rate via a central sympathetic mechanism.

  2016cites this paper
• Ion Channels in Obesity: Pathophysiology and Potential Therapeutic Targets

  2016cites this paper
• The brain renin-angiotensin system in metabolic and cardiovascular regulation

  2016cites this paper
• Leptin as a Mediator of Obesity-Induced Hypertension

  2016cites this paper
• more spice Dietary salt and hypertension: new molecular targets add

  2016cites this paper
• Leptin, the Autonomic Nervous System, and Hypertension

  2015cites this paper
• Blood pressure, heart rate and tubuloglomerular feedback in A1AR‐deficient mice with different genetic backgrounds

  2015cites this paper
• Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin.

  2015cites this paper
• The discovery of hypertension: evolving views on the role of the kidneys, and current hot topics.

  2015cites this paper
• Brain-mediated antidiabetic, anorexic, and cardiovascular actions of leptin require melanocortin-4 receptor signaling.

  2015cites this paper
• Chronic Central Nervous System MC3/4R Blockade Attenuates Hypertension Induced by Nitric Oxide Synthase Inhibition but Not by Angiotensin II Infusion

  2015cites this paper
• New developments in the pathogenesis of obesity-induced hypertension.

  2015cites this paper
• Roles of the Melanocortin-4 Receptor in Gut-Brain Communication

  2014cites this paper
• Central Nervous System Dysfunction in Obesity-Induced Hypertension

  2014cites this paper
• Approach to assessing determinants of glucose homeostasis in the conscious mouse

  2014cites this paper
• Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs

  2014cites this paper
• The brain melanocortin system, sympathetic control, and obesity hypertension.

  2014cites this paper
• Role of Gsα in Central Regulation of Energy and Glucose Metabolism

  2014cites this paper
• Neural melanocortin receptors in obesity and related metabolic disorders.

  2014cites this paper
• Leptin Mediates the Increase in Blood Pressure Associated with Obesity

  2014cites this paper
• Neuroanatomical determinants of the sympathetic nerve responses evoked by leptin

  2013cites this paper
• Hypertension in obesity: is leptin the culprit?

  2013cites this paper
• Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity.

  2013cites this paper
• Control of metabolic and cardiovascular function by the leptin–brain melanocortin pathway

  2013cites this paper
• Chronic central ghrelin infusion reduces blood pressure and heart rate despite increasing appetite and promoting weight gain in normotensive and hypertensive rats.

  2013cites this paper
• Obese melanocortin-4 receptor-deficient rats exhibit augmented angiogenic balance and vasorelaxation during pregnancy

  2013cites this paper
• Chronic Treatment With a Melanocortin-4 Receptor Agonist Causes Weight Loss, Reduces Insulin Resistance, and Improves Cardiovascular Function in Diet-Induced Obese Rhesus Macaques

  2013cites this paper
• Vascular effects of deletion of melanocortin-4 receptors in rats

  2013cites this paper
• Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons.

  2013cites this paper
• Generation of porcine fibroblasts overexpressing 11β-HSD1 with adipose tissue-specific aP2 promoter as a porcine model of metabolic syndrome.

  2013cites this paper
• Role of leptin and central nervous system melanocortins in obesity hypertension

  2013cites this paper
• Prolyl carboxypeptidase and its inhibitors in metabolism.

  2013cites this paper
• New perspectives on the melanocortins and their cardiovascular effects: Potential implications for the treatment of cardiovascular diseases with melanocortin analogues

  2013cites this paper
• Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels.

  2013cites this paper
• Cardiovascular Influences on Blood Pressure

  2013cites this paper
• Hormones corticolipotropes et endorphines

  2013cites this paper
• Prolylcarboxypeptidase protects from vascular dysfunction and promotes vascular repair

  2013cites this paper
• Metabolic Syndrome in the Rural Population of Wardha, Central India: An Exploratory Factor Analysis

  2013cites this paper
• Chapter 11 – Animal Models of Metabolic Syndrome

  2013cites this paper